Computer Aided Detection (CAD)

Global Computer Aided Detection (CAD) Market to Reach US$2.0 Billion by 2030

The global market for Computer Aided Detection (CAD) estimated at US$1.2 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2024-2030. Mammography, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the end of the analysis period. Growth in the MRI segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$305.5 Million While China is Forecast to Grow at 12.4% CAGR

The Computer Aided Detection (CAD) market in the U.S. is estimated at US$305.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$458.0 Million by the year 2030 trailing a CAGR of 12.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized

Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.

Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.

The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.

 

SCOPE OF STUDY:

The report analyzes the Computer Aided Detection (CAD) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Imaging Modality (Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT, Other Imaging Modalities); Application (Oncology, Cardiovascular & Neurological Indications)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 103 Featured) -

• Agfa-Gevaert NV
• FUJIFILM Holdings Corporation
• GE Healthcare
• Hitachi Ltd.
• Hologic, Inc.
• iCAD, Inc.
• Invivo Corporation
• Koninklijke Philips NV
• McKesson Corporation
• Merge Healthcare, Inc.
• Siemens Healthineers

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more